Literature DB >> 32740824

Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines.

Ga-Young Lee1,2,3, Jin-Seok Lee2,3, Chang-Gue Son2,3, Nam-Hun Lee4,5,6.   

Abstract

Colorectal cancer (CRC) is one of the most prevalent and lethal cancer types around the world. Most of the CRC patients are treated with chemotherapeutic drugs alone or combined. However, up to 90% of metastatic cancer patients experience the failure of treatment mostly because of the acquired drug resistance, which can be led to multidrug resistance (MDR). In this study, we reviewed the recent literature which studied potential CRC MDR reversal agents among herbal medicines (HMs). Among abundant HMs, 6 single herbs, Andrographis paniculata, Salvia miltiorrhiza, Hedyotis diffusa, Sophora flavescens, Curcuma longa, Bufo gargarizans, and 2 formulae, Pien Tze Huang and Zhi Zhen Fang, were found to overcome CRC MDR by two or more different mechanisms, which could be a promising candidate in the development of new drugs for adjuvant CRC chemotherapy.
© 2020. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  colorectal cancer; drug resistance; herbal medicine

Year:  2020        PMID: 32740824     DOI: 10.1007/s11655-020-3425-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  109 in total

Review 1.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.

Authors:  S T Taylor; J A Hickman; C Dive
Journal:  J Natl Cancer Inst       Date:  2000-01-05       Impact factor: 13.506

Review 4.  P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.

Authors:  Tolga Eichhorn; Thomas Efferth
Journal:  J Ethnopharmacol       Date:  2011-09-21       Impact factor: 4.360

Review 5.  Molecular mechanisms of drug resistance.

Authors:  D B Longley; P G Johnston
Journal:  J Pathol       Date:  2005-01       Impact factor: 7.996

Review 6.  Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.

Authors:  Prashant Joshi; Ram A Vishwakarma; Sandip B Bharate
Journal:  Eur J Med Chem       Date:  2017-06-27       Impact factor: 6.514

Review 7.  Research Progress on Reversing Multidrug Resistance in Tumors by Using Chinese Medicine.

Authors:  Huan-Dong Zhao; Hong-Juan Xie; Jian Li; Cai-Ping Ren; Yu-Xiang Chen
Journal:  Chin J Integr Med       Date:  2018-06-02       Impact factor: 1.978

Review 8.  Cancer drug resistance: an evolving paradigm.

Authors:  Caitriona Holohan; Sandra Van Schaeybroeck; Daniel B Longley; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

9.  ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal.

Authors:  Cheol-Hee Choi
Journal:  Cancer Cell Int       Date:  2005-10-04       Impact factor: 5.722

Review 10.  Overcome Cancer Cell Drug Resistance Using Natural Products.

Authors:  Pu Wang; Hua Li Yang; Ying Juan Yang; Lan Wang; Shao Chin Lee
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-01       Impact factor: 2.629

View more
  5 in total

Review 1.  Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy.

Authors:  Jin-Feng Xu; Yan Wan; Fei Tang; Lu Chen; Yu Yang; Jia Xia; Jiao-Jiao Wu; Hui Ao; Cheng Peng
Journal:  Front Pharmacol       Date:  2021-12-17       Impact factor: 5.810

2.  LIM-Domain-Binding Protein 1 Mediates Cell Proliferation and Drug Resistance in Colorectal Cancer.

Authors:  Mo Zhu; Baofei Jiang; Hao Zuo; Xiaopeng Wang; Hengfa Ge; Ziming Huang
Journal:  Front Surg       Date:  2022-01-06

3.  Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway.

Authors:  Cheng Wang; Miaomiao Yang; Xi Gu; Yanjing Gu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 4.  Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery.

Authors:  Qiang Sun; Man He; Meng Zhang; Sha Zeng; Li Chen; Hui Zhao; Han Yang; Maolun Liu; Shan Ren; Haibo Xu
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

5.  Coptidis Rhizoma Extract Reverses 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells via Modulation of Thymidylate Synthase.

Authors:  Yong-Hwi Kang; Jin-Seok Lee; Nam-Hun Lee; Seung-Hyung Kim; Chang-Seob Seo; Chang-Gue Son
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.